We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
CNS portfolio


Neuraxpharm has one of the most extensive product portfolios in CNS pharmaceuticals in Europe to offer patients
and medical specialists affordable cutting-edge CNS pharmaceuticals
  • full coverage of psychiatrists & neurologists Comprehensive marketed portfolio of >130 CNS molecules in all major categories
  • partner for specialist doctors Unique molecules in the market
  • Advisory board with 6 KOLs
Added value dosage forms and strengths
  • CNS foundation Cross-country synergies in portfolio
CNS pharmaceuticals
  • Our strength comes from offering one of the most comprehensive product portfolios in CNS pharmaceuticals in Europe
  • We offer a complete spectrum of therapeutic options in Epilepsy, Parkinson's, Antipsychotics, Depression and Alzheimer's as well as a growing portfolio in other CNS indications
  • Our product portfolio includes >130 CNS molecules in the categories of Analgesics, Antidementia agents, Antidepressants, Antiepileptics, Antiparkinson agents, Antipsychotics, Anxiolytics/Hypnotics and other CNS categories
Comprehensive marketed portfolio of >130 CNS molecules in all major categories
  • We are experts in improving existing pharmaceutical forms and in upgrading new products. In some cases, new patient-friendly products and formulations are developed at the request of, and in close consultation with, medical specialists

  • Our extensive portfolio includes not only high-turnover products and conventional pharmaceutical forms but, thanks to Neuraxpharm’s intense patient focus, we can also provide less popular preparations and offer products in a comprehensive, patient-friendly range of active substances in well-tolerated forms, along with a very wide range of dosages for personalised treatment
Unique molecules in the market

  • It is part of Neuraxpharm’s very identity to be able to offer patients and medical specialists affordable cutting-edge CNS drugs

  • Medicines are improved by innovative advancements in their pharmaceutical forms and by more practical dosing
cutting-edge CNS pharmaceuticals

  • The integration of all the companies within Neuraxpharm allows us to establish both growth and cross-business synergies in many strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion